IP Library Patent Application 17217752
Patent Application
App. No. 17/217,752

MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/217,752
Abstract

The present invention provides, among other things, methods and compositions for large-scale production of capped mRNA using SUMO-Guanylyl Transferase fusion protein.

Claims (24)

1 .- 6 . (canceled)

7 . A fusion protein, wherein the fusion protein comprises guanylyl transferase and a small ubiquitin-like molecule (SUMO) protein comprising 90% identity to SEQ ID NO: 8 and SEQ ID NO: 7.

8 . The fusion protein of claim 7 , wherein the guanylyl transferase comprises SEQ ID NO: 8 and SEQ ID NO: 7.

9 .- 10 . (canceled)

11 . The fusion protein of claim 7 , wherein the fusion protein has comparable phosphatase activity, guanylyl transferase activity and methylation activity relative to a wild-type guanylyl transferase protein.

12 . A vector encoding a fusion protein comprising guanylyl transferase protein and a small ubiquitin-like molecule (SUMO) protein.

13 . The vector of claim 12 , wherein the vector comprises SEQ ID NO: 1 and SEQ ID NO: 2.

14 . The vector of claim 12 , wherein the vector comprises SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3.

15 . The vector of claim 12 , wherein the vector comprises SEQ ID NO: 4 and SEQ ID NO: 3.

16 . A method to produce a guanylyl transferase by fermentation, comprising: a) culturing in a fermentation medium a microorganism that is transformed with at least one recombinant nucleic acid molecule comprising a nucleic acid sequence encoding a guanylyl transferase fusion protein that has an amino acid sequence that is at least 90% identical to SEQ ID NO: 8 and SEQ ID NO: 7; and b) collecting a product produced from the step of culturing.

17 . (canceled)

18 . The method of claim 16 , wherein the guanylyl transferase fusion protein has comparable phosphatase activity, guanylyl transferase activity and methylation activity relative to a wild-type guanylyl transferase protein.

19 . The method of claim 16 , wherein the guanylyl transferase fusion protein comprises a small ubiquitin-like molecule (SUMO) protein.

20 . The method of claim 19 , wherein the guanylyl transferase fusion protein comprises SEQ ID NO: 8.

21 . The method of claim 19 , wherein the SUMO protein is bound to the guanylyl transferase by a covalent link.

22 . The method of claim 21 , wherein the covalent link is between the SUMO protein and a large subunit of the guanylyl transferase.

23 . The method of claim 16 , wherein the fermentation medium is selected from the group consisting of Terrific Broth, Cinnabar, 2×YT and LB.

24 . The method of claim 16 , wherein the microorganism is a bacterium.

25 . The method of claim 16 , wherein the nucleic acid sequence encoding the guanylyl transferase is at least 90% identical to SEQ ID NO: 2 and SEQ ID NO: 3.

26 . The method of claim 16 , wherein the recombinant nucleic acid molecule further comprises a nucleic acid sequence encoding a small ubiquitin-like molecule (SUMO) protein.

27 . The method of claim 26 , wherein the nucleic acid sequence encoding a small ubiquitin-like molecule (SUMO) protein is at least 90% identical to SEQ ID NO: 1.

28 . The method of claim 16 , wherein the product is a guanylyl transferase.

29 . The method of claim 28 , wherein the product is a guanylyl transferase fusion protein that further comprises a small ubiquitin-like molecule (SUMO) protein.

30 . (canceled)

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2021
From: STRACK-LOGUE, BETTINA; DEROSA, FRANK; HEARTLEIN, MICHAEL
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 056796/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: RANA THERAPEUTICS, INC.
Reel/Frame 056806/0881 →
CHANGE OF NAME Recorded Jul 8, 2021
From: RANA THERAPEUTICS, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 056806/0943 →